Cas:1213651-35-4 (1S)-1-(3-fluoro-2-methylphenyl)propan-1-amine,hydrochloride manufacturer & supplier

Chemical Name:(1S)-1-(3-fluoro-2-methylphenyl)propan-1-amine,hydrochloride

CAS.NO:1213651-35-4

Synonyms:(1S)-1-(3-FLUORO-2-METHYLPHENYL)PROPYLAMINE-HCl;(S)-1-(3-Fluoro-2-methylphenyl)propan-1-amine hydrochloride;(1s)-1-(3-fluoro-2-methylphenyl)propylamine hydrochloride

Molecular Formula:C₁₀H₁₅ClFN

Molecular Weight:203.68400

HS Code:2921499090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:26.02000

Exact Mass:203.08800

LogP:4.04620

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (1S)-1-(3-FLUORO-2-METHYLPHENYL)PROPYLAMINE-HCl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1s)-1-(3-fluoro-2-methylphenyl)propylamine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1S)-1-(3-FLUORO-2-METHYLPHENYL)PROPYLAMINE-HCl Use and application,(1S)-1-(3-FLUORO-2-METHYLPHENYL)PROPYLAMINE-HCl technical grade,usp/ep/jp grade.

Related News: The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development. (1S)-1-(3-fluoro-2-methylphenyl)propan-1-amine,hydrochloride manufacturer High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies. (1S)-1-(3-fluoro-2-methylphenyl)propan-1-amine,hydrochloride supplier The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development. (1S)-1-(3-fluoro-2-methylphenyl)propan-1-amine,hydrochloride vendor High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies. (1S)-1-(3-fluoro-2-methylphenyl)propan-1-amine,hydrochloride factory But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone.